Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two new studies come to different conclusions about the risk for severe illness and death.
The results point the way toward a universal coronavirus vaccine that could prevent future pandemics.
The immune response to the single-shot Johnson & Johnson vaccine remained robust against variants of SARS-CoV-2.
Some people with blood cancers, however, may not be as well protected.
MOMI-VAX researchers will evaluate antibody responses in vaccinated participants and their infants.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
The protein subunit vaccine provides 100% protection against moderate or severe disease, hospitalization and death.
After reviewing thousands of blood donations, researchers found no reason to alter current screening practices.
The Pfizer-BioNTech vaccine was 100% effective in a study of adolescents; trials for younger children are now underway.
Vaccine hesitancy among racial and ethnic minorities has faded, and confidence in vaccines is growing even among Republicans.
Many experts argue that COVID-19 cannot be curbed without vaccinating children. But others aren’t so sure.
The CDC and FDA confirmed that the vaccine is safe, and said the recent pause should be lifted for all groups.
Scientific evidence appears to show that vaccine-induced immunity is stronger than what the body generates after natural infection.
The federal government has paused administration of the vaccine while it investigates a rare blood clotting disorder.
Experts don’t yet know what causes long COVID or why some people have persistent symptoms while others recover in weeks or even days.
Funding can be used for partnerships with community-based organizations to increase vaccine uptake, including for underserved groups.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.